Close Menu

NEW YORK (GenomeWeb) – Plant Bioscience Limited announced today that it has granted a worldwide, non-exclusive license to a series of RNAi-related patents to Thermo Fischer Scientific for use with its research reagents and kits.

The deal specifically covers nine US patents related to small RNA-triggered post-transcriptional gene silencing and based on the plant work of Sainsbury Laboratory researchers David Baulcombe and Andrew Hamilton. 

Financial terms of the arrangement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.